Why was this study done?
depression, CVD, anxiety
CVD, CARDIOVASCULAR DISEASE
One-third of cardiovascular disease (CVD) patients suffer anxiety and depression symptoms, but psychological support in cardiac rehabilitation (CR) is limited and produces small effects.Treating anxiety and depression is important because they are associated with worse health outcomes and impair quality of life.Previously, a recent treatment called metacognitive therapy (MCT) significantly improved anxiety and depression in patients undergoing CR when delivered by cardiac staff.Home-based self-help MCT was previously found to be feasible and acceptable to deliver alongside CR, hence a full-scale trial was required to test the effectiveness of this self-help intervention.